Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
| ▸ | GPBAR1 | Q8TDU6 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CCR9 | P51686 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29582525 | 1.00 | GAA (0.36) | GAAGRIN1GRIN2BGPBAR1MAPT | |
| SCHEMBL25201217 | 0.89 | MAPT (0.34) | MAPTLMNAKMT2A | |
| SCHEMBL30389235 | 0.89 | MAPT (0.34) | MAPTLMNAKMT2A | |
| SCHEMBL22031792 | 0.89 | CASR (0.40) | MAPTLMNAKMT2A | |
| SCHEMBL22084636 | 0.86 | LMNA (0.36) | MAPTLMNAKMT2A | |
| SCHEMBL22031854 | 0.85 | CYP1A2 (0.38) | MAPTP2RX7LMNA | |
| SCHEMBL22085782 | 0.84 | MAPT (0.37) | MAPTP2RX7LMNAKMT2A | |
| SCHEMBL22906297 | 0.83 | LMNA (0.40) | MAPTLMNAKMT2A | |
| SCHEMBL25180883 | 0.83 | GRIN2B (0.33) | GAAGRIN1GRIN2BMAPTLMNA | |
| SCHEMBL30388667 | 0.83 | GRIN2B (0.33) | GAAGRIN1GRIN2BMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3890487-B1 | HERBICIDAL COMPOSITIONS | SYNGENTA PARTICIPATIONS AG (CH) | 2024-06-12 | — | — | EP | claimed |
| US-20230301300-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-09-28 | — | — | US | disclosed |
| US-20230301300-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-09-28 | — | — | US | disclosed |
| US-20220119353-A1 | Herbicidal Compositions | SYNGENTA PARTICIPATIONS AG (CH) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230301300-A1 | HERBICIDAL COMPOSITIONS | GMDS, DDT, AADAC | GAA 687/4885GRIN1 1599/4885GRIN2B 1740/4885 |
| US-20220119353-A1 | Herbicidal Compositions | DDT, HPD, PNPO | GAA 736/4885GRIN1 2343/4885GRIN2B 2195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.